InvestSMART

Recce Pharmaceuticals Ltd (ASX: RCE) - Announcements

Current share price for RCE : $0.365 0.01 (2.67%)+

ASX company news and announcements for Recce Pharmaceuticals Ltd (RCE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Recce Pharmaceuticals Ltd (RCE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Recce Pharmaceuticals Ltd (RCE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Recce Pharmaceuticals Ltd (RCE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$112 Half Yearly Report and Accounts 27 Feb 2019 3:01PM $0.145 $0.365 risen by 151.72%
$112 Change in substantial holding 15 Feb 2019 3:11PM $0.165 $0.365 risen by 121.21%
$112 Change of Director's Interest Notice 15 Feb 2019 3:10PM $0.165 $0.365 risen by 121.21%
$112 Cleansing Statement 15 Feb 2019 3:06PM $0.165 $0.365 risen by 121.21%
$112 Notice under ASX Listing Rule 3.10.5A 15 Feb 2019 3:06PM $0.165 $0.365 risen by 121.21%
$112 Issue of Securities and Appendix 3B 15 Feb 2019 3:01PM $0.165 $0.365 risen by 121.21%
$112 Recce Successfully Raises $1.8 million via Placement 8 Feb 2019 10:08AM $0.170 $0.365 risen by 114.71%
$112 Trading Halt 6 Feb 2019 9:47AM $0.170 $0.365 risen by 114.71%
$112 Appendix 4C and commentary 31 Jan 2019 5:53PM $0.165 $0.365 risen by 121.21%
$112 R&D Incentive Rebate Received 31 Jan 2019 3:52PM $0.165 $0.365 risen by 121.21%
$112 Funding Update 18 Jan 2019 9:27AM $0.150 $0.365 risen by 143.33%
$112 Funding Update 16 Jan 2019 4:34PM $0.175 $0.365 risen by 108.57%
$112 Funding Update 18 Dec 2018 1:40PM $0.165 $0.365 risen by 121.21%
$112 Company Constitution 3 Dec 2018 12:09PM $0.185 $0.365 risen by 97.30%
$112 Results of Meeting 29 Nov 2018 1:10PM $0.180 $0.365 risen by 102.78%
$112 Funding Update 23 Nov 2018 10:05AM $0.180 $0.365 risen by 102.78%
$112 Investor Presentation 21 Nov 2018 9:36AM $0.180 $0.365 risen by 102.78%
$112 Appendix 4C and commentary 1 Nov 2018 8:35AM $0.180 $0.365 risen by 102.78%
$112 Notice of General Meeting/Proxy Form 29 Oct 2018 5:42PM $0.180 $0.365 risen by 102.78%
$112 Recce Meets Antibiotic Leaders to Explore Opportunities 25 Oct 2018 8:59AM $0.175 $0.365 risen by 108.57%
$112 Date of 2018 Annual General Meeting 8 Oct 2018 6:14PM $0.180 $0.365 risen by 102.78%
$112 R&D Incentive Rebate Received 2 Oct 2018 4:41PM $0.175 $0.365 risen by 108.57%
$112 Appendix 4G 28 Sep 2018 4:15PM $0.175 $0.365 risen by 108.57%
$112 2018 Annual Report 28 Sep 2018 4:10PM $0.175 $0.365 risen by 108.57%
$112 Change of Registry Address: Automic P/L - Sydney Office 28 Sep 2018 12:27PM $0.175 $0.365 risen by 108.57%

526 - 550 of 725 results

Page 22 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.